1. DooleyKE, ChaissonRE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9: 737–746.
2. BaderMS (2008) Diabetic foot infection. Am Fam Physician 78: 71–79.
3. YanoH, KinoshitaM, FujinoK, NakashimaM, YamamotoY, et al. (2002) Insulin treatment directly restores neutrophil phagocytosis and bactericidal activity in diabetic mice and thereby improves surgical site Staphylococcus aureus infection. Infect Immun 80: 4409–4416.
4. HansesF, ParkS, RichJ, LeeJC (2011) Reduced neutrophil apoptosis in diabetic mice during Staphylococcal infection leads to prolonged Tnfα production and reduced neutrophil clearance. PLoS ONE 6: e23633 doi:10.1371/journal.pone.0023633
5. BreenJD, KarchmerAW (1995) Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am 9: 11–24.
6. JacobssonG, DashtiS, WahlbergT, AnderssonR (2007) The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 39: 6–13.
7. SkoffTH, FarleyMM, PetitS, CraigAS, SchaffnerW, et al. (2009) Increasing burden of invasive group B streptococcal disease in non-pregnant adults, 1990–2007. Clin Infect Dis 49: 85–92.
8. LinYT, WangFD, WuPF, FungCP (2013) Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics. BMC Infect Dis 13: 56.
9. GeerlingsSE (2008) Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31 Suppl 1 554–557.
10. LeungCC, LamTH, ChanWM, YewWW, HoKS, et al. (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167: 1486–1494.
11. Pablos-MendezA, BlusteinJ, KnirschCA (1997) The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 87: 574–579.
12. LeegaardA, RusA, KornumJB, PrahlJB, TomsenVO, et al. (2011) Diabetes, glycemic control, and risk of tuberculosis. A population-based case-control study. Diabetes Care 34: 2530–2535.
13. ChengAC, CurrieBJ (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383–416.
14. ChanchamroenS, KewcharoenwongC, SusaengratW, AtoM, LertmemongkolchaiG (2009) Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 77: 456–63.
15. RiyapaD, BuddhisaS, KorbsrisateS, CuccuiJ, WrenBW, et al. (2012) Neutrophil Extracellular Traps exhibit antibacterial activity against Burkholderia pseudomallei and are influenced by bacterial and host factors. Infect Immun 80: 3921–3929.
16. GomezDI, TwahirwaM, SchlesingerLS, RestrapoBI (2013) Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis 93: 192–197.
17. PelegAY, WeerarathnaT, MacarthyJS, DavisTME (2007) Common infections in diabetes: pathogenesis, management and relationship to glycemic control. Diabetes Metab Res Rev 23: 3–13.
18. RayfieldEJ, AultMJ, KeuschGT, BrothersMJ, MechemiasC, et al. (1982) Infection and diabetes: the case for glucose control. Am J Med 72: 439–450.
19. RichJ, LeeJC (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54: 2904–2910.
20. TanKS, LeeKO, LowKC, GamageAM, LiuY, et al. (2012) Glutathione deficiency in Type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122: 2289–2300.
21. StegengaME, van der CrabbenSN, BlumerRME, LeviM, MeijersJCM, et al. (2008) Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112: 82–89.
22. BerhausA, HoffmanMA, ZieglerR, NawrothPP (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37: 586–600.
23. IlyasR, WallisR, SoilleuxEJ, TownsendP, ZehnderD, et al. (2010) High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology 216: 126–131.
24. ZwangTJ, GormallyMV, JohalMS, SazinskyMH (2012) Enhanced iron availability by protein glycation may explain higher infection rates in diabetics. Biometals 25: 237–245.
25. CollisonKS, ParharRS, SalehSS, MeyerBF, KwaasiAA, et al. (2002) RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71: 433–444.
26. WangMC, TsengCC, WuAB, LinWH, TenCH, et al. (2013) Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect 46: 24–29.
27. GeerlingsSE, MeilandR, van LithEC, BrouwerEC, GaastraW, et al. (2002) Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 25: 1405–1409.
28. KnightSD, BouckaertJ (2009) Structure, function and assembly of the type 1 fimbraie. Top Curr Chem 288: 67–107.
29. TagannaJ, de BoerAR, WuhrerM, BouckaertJ (2011) Glycosylation changes as important factors for the susceptibility to urinary tract infection. Biochem Soc Trans 39: 349–354.
30. GarnettJP, BakerEH, NaikS, LindsayJA, KnightGM, et al. (2013) Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax 68: 835–845.
31. BrownleeM (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813–20.
32. KohGCKW, SchreiberMF, BautistaR, MaudeRR, DunachieS, et al. (2013) Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signalling. PLoS ONE 8: e54961 doi:10.1371/journal.pone.0054961
33. MorrisD, KhurasanyM, NguyenT, KimJ, GuikfordF, et al. (2013) Glutathione and infection. Biochimie et Biophysica Acta 1830: 3329–3349.